Ballast Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $451K | Buy |
2,427
+69
| +3% | +$12.8K | 0.13% | 76 |
|
|
2025
Q1 | $494K | Sell |
2,358
-316
| -12% | -$66.2K | 0.16% | 71 |
|
|
2024
Q4 | $475K | Buy |
2,674
+137
| +5% | +$24.3K | 0.15% | 73 |
|
|
2024
Q3 | $501K | Sell |
2,537
-184
| -7% | -$36.3K | 0.15% | 71 |
|
|
2024
Q2 | $467K | Buy |
2,721
+171
| +7% | +$29.3K | 0.15% | 73 |
|
|
2024
Q1 | $464K | Sell |
2,550
-169
| -6% | -$30.8K | 0.16% | 74 |
|
|
2023
Q4 | $421K | Buy |
2,719
+2
| +0.1% | +$310 | 0.16% | 77 |
|
|
2023
Q3 | $405K | Sell |
2,717
-83
| -3% | -$12.4K | 0.16% | 79 |
|
|
2023
Q2 | $377K | Sell |
2,800
-72
| -3% | -$9.7K | 0.14% | 78 |
|
|
2023
Q1 | $458K | Buy |
2,872
+74
| +3% | +$11.8K | 0.18% | 58 |
|
|
2022
Q4 | $452K | Sell |
2,798
-43
| -2% | -$6.95K | 0.2% | 57 |
|
|
2022
Q3 | $381K | Sell |
2,841
-23
| -0.8% | -$3.08K | 0.18% | 62 |
|
|
2022
Q2 | $439K | Buy |
2,864
+25
| +0.9% | +$3.83K | 0.2% | 61 |
|
|
2022
Q1 | $460K | Buy |
2,839
+1
| +0% | +$162 | 0.18% | 66 |
|
|
2021
Q4 | $384K | Buy |
2,838
+1
| +0% | +$135 | 0.15% | 76 |
|
|
2021
Q3 | $306K | Buy |
2,837
+2
| +0.1% | +$216 | 0.13% | 86 |
|
|
2021
Q2 | $319K | Sell |
2,835
-284
| -9% | -$32K | 0.13% | 79 |
|
|
2021
Q1 | $338K | Buy |
3,119
+191
| +7% | +$20.7K | 0.16% | 72 |
|
|
2020
Q4 | $314K | Buy |
2,928
+2
| +0.1% | +$214 | 0.16% | 74 |
|
|
2020
Q3 | $256K | Buy |
2,926
+1
| +0% | +$87 | 0.16% | 77 |
|
|
2020
Q2 | $287K | Buy |
+2,925
| New | +$287K | 0.2% | 66 |
|
|
2020
Q1 | – | Sell |
-2,616
| Closed | -$232K | – | 155 |
|
|
2019
Q4 | $232K | Buy |
+2,616
| New | +$232K | 0.17% | 84 |
|